The Pharmaceutical Industry has a strong need to develop knowledge from data. Although the latter is not at a premium in the Pharmaceutical Industry the former is, as always, at a premium. Multivariate data analysis (MVA) is a set of statistical data analytical methods which has  been widely adopted within the Pharmaceutical Industry, and it has pre-eminence within the discipline. The ability of MVA to provide validatable solutions within a Regulated Pharmaceutical environment has arisen because of its transparency and reproducibility, across a wide field of data sources. An ecosystem of software providers, allied with hardware solutions, means that the  techniques are becoming widely understood and applied. Key to this adoption has been the ability of MVA techniques to meet not only direct Regulatory Guidance, but also Industry Standards such as ICH Q8 and initiatives such as Quality by Design. A wide body of literature is now available which explains how to use the technique appropriately, so that these Guidances can be met, leading to robust solutions

Hora

11:00 - 12:00 hs GMT+1

Organizador

BioPharma Asia Magazine
Compartir
Enviar a un amigo
Mi email *
Email destinatario *
Comentario *
Repite estos números *
Control de seguridad
Junio / 2019 721 webinars
Lunes
Martes
Miércoles
Jueves
Viernes
Sábado
Domingo
Lun 27 de Junio de 2019
Mar 28 de Junio de 2019
Mié 29 de Junio de 2019
Jue 30 de Junio de 2019
Vie 31 de Junio de 2019
Sáb 01 de Junio de 2019
Dom 02 de Junio de 2019
Lun 03 de Junio de 2019
Mar 04 de Junio de 2019
Mié 05 de Junio de 2019
Jue 06 de Junio de 2019
Vie 07 de Junio de 2019
Sáb 08 de Junio de 2019
Dom 09 de Junio de 2019
Lun 10 de Junio de 2019
Mar 11 de Junio de 2019
Mié 12 de Junio de 2019
Jue 13 de Junio de 2019
Vie 14 de Junio de 2019
Sáb 15 de Junio de 2019
Dom 16 de Junio de 2019
Lun 17 de Junio de 2019
Mar 18 de Junio de 2019
Mié 19 de Junio de 2019
Jue 20 de Junio de 2019